News for 'Internal Medicine'

Arabs alleging Islamophobia in India is propaganda: MEA

Arabs alleging Islamophobia in India is propaganda: MEA

Rediff.com1 May 2020

Strongly rebutting the charges, External Affairs Ministry Spokesperson Anurag Srivastava said the Gulf countries are deeply committed to friendly relations with India and they are even seeking bilateral talks on the post-COVID-19 economic recovery. Talking about India's close and traditional ties with the Arab countries, he said New Delhi is ensuring uninterrupted supply of food and essential commodities to the region during Ramzan as part of its deep-rooted friendship.

NPPA slaps Rs 300-crore penalty on Novartis

NPPA slaps Rs 300-crore penalty on Novartis

Rediff.com13 Oct 2014

Drug major Novartis has been slapped with a Rs 300-crore penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine.

Govt fighting swine flu with ayurvedic meds and isolation wards

Govt fighting swine flu with ayurvedic meds and isolation wards

Rediff.com20 Feb 2015

A day after death toll due to swine flu crossed 700, Union Minister of State for Health Shripad Naik said the Centre is sending special ayurvedic medicinal syrups to all states as part of its efforts to combat the influenza.

Health conditions your face reveals

Health conditions your face reveals

Rediff.com10 Mar 2011

According to Chinese medicine, your face serves as a window to your internal health.

Rebalancing India-China, The Sri Lanka Way

Rebalancing India-China, The Sri Lanka Way

Rediff.com14 Feb 2022

Colombo seems to be veering to the middle path between China and the US on global matters, but in regional matters of strategic security, it is increasingly identifying with India, points out N Sathiya Moorthy.

UNSC's first Covid-19 resolution backs India's stand

UNSC's first Covid-19 resolution backs India's stand

Rediff.com2 Jul 2020

The resolution, drafted by France and Tunisia, 'demands a general and immediate cessation of hostilities in all situations on its agenda and supports the efforts undertaken by the Secretary-General and his Special Representatives and Special Envoys'.

India's COVID-19 figures worrying: WHO chief scientist

India's COVID-19 figures worrying: WHO chief scientist

Rediff.com11 May 2021

Soumya Swaminathan called on governments to boost exercises on reporting actual numbers.

4 JeM terrorists killed in 3-hr-long gunbattle in J-K

4 JeM terrorists killed in 3-hr-long gunbattle in J-K

Rediff.com19 Nov 2020

Central Reserve Police Force and police personnel moved to search the vehicle and came under fire of the terrorists hiding in the truck. They retaliated resulting in an encounter.

'We have done our best, far earlier compared to the rest of the world'

'We have done our best, far earlier compared to the rest of the world'

Rediff.com22 Apr 2020

'On January 17, we had our first meeting with the Cabinet secretary.' 'Different secretaries belonging to different departments attended it.' 'It was only two weeks when China had said there is a new disease.' 'So, we gave the quickest response.'

Delhi CM announces 6 day lockdown starting Monday night

Delhi CM announces 6 day lockdown starting Monday night

Rediff.com19 Apr 2021

According to sources, all private offices will work from home and only government offices and essential services will be open.

SEE: Stranded Indian students appeal for help

SEE: Stranded Indian students appeal for help

Rediff.com19 Mar 2020

'We are feeling helpless and want to be with our families.'

Should yoga therapy go the Western way?

Should yoga therapy go the Western way?

Rediff.com7 Feb 2019

Why must Indians adjust their time-tested system because of what the West needs, asks Sanjeev Nayyar.

Will Tokyo Olympics happen in 2021?

Will Tokyo Olympics happen in 2021?

Rediff.com26 May 2021

Japan's Asahi Shimbun, an official partner of the Tokyo 2020 Olympics, called for the Summer Games to be cancelled in an editorial

Wait for cheaper drugs might get longer

Wait for cheaper drugs might get longer

Rediff.com3 Mar 2016

Lobby group tells USTR it has got assurance from India on compulsory licensing.

The intriguing tale of India's trade with North Korea

The intriguing tale of India's trade with North Korea

Rediff.com16 Jun 2018

India remains North Korea's 2nd-largest import source after China, according to several estimates by multilateral bodies, says Subhayan Chakraborty.

Dead bodies pile up, epidemic fears rise, but govt not leery

Dead bodies pile up, epidemic fears rise, but govt not leery

Rediff.com30 Jun 2013

Many feel the fear of epidemic outbreak will grow severe in around a month and once the rainy season gets over, reports Sushmi Dey

PE/VC investments in pharma cos cross $1 bn mark

PE/VC investments in pharma cos cross $1 bn mark

Rediff.com6 Oct 2020

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.

Would rather talk to Kashmiri youth than Pak: Shah to Farooq

Would rather talk to Kashmiri youth than Pak: Shah to Farooq

Rediff.com26 Oct 2021

Shah said "three families" are answerable to the people for their failure to develop Jammu and Kashmir over the past seven decades.

'Putin is a goonda'

'Putin is a goonda'

Rediff.com28 Mar 2022

'Sholay wallah kahani hai: 'Gabbar Singh aayega, Gabbar Singh aayega.' 'But what is inside Gabbar Singh nobody knows.'

With Rs 62,398 crore, health budget sees a 19% rise

With Rs 62,398 crore, health budget sees a 19% rise

Rediff.com5 Jul 2019

The budgetary allocation for the sector is Rs 60,908.22 crore, with Rs 6,400 crore earmarked for the centre's flagship health insurance scheme Ayushman Bharat- Pradhan Mantri Jan Arogya Yojna (AB-PMJAY).

Coronavirus: How India Inc is tackling the crisis

Coronavirus: How India Inc is tackling the crisis

Rediff.com5 Mar 2020

Across the country, companies have stepped up their act to contain the crisis. IT and other new economy firms seem to have taken a lead.

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Rediff.com12 Sep 2020

AstraZeneca and the University of Oxford, as the trial sponsor, said that they cannot disclose further medical information but confirmed that independent investigations concluded that the trials were safe to restart.

Top destinations for Indians to study abroad

Top destinations for Indians to study abroad

Rediff.com12 Jun 2018

China, France and Spain are emerging as hotspots for Indian students.

Before Obama visit, US drug firms lobby for ease of doing business

Before Obama visit, US drug firms lobby for ease of doing business

Rediff.com5 Jan 2015

Unlike India, the US is a free-pricing market.

Back injury threatens Coulter-Nile's Ashes dream

Back injury threatens Coulter-Nile's Ashes dream

Rediff.com10 Nov 2017

Australia fast bowler Nathan Coulter-Nile could miss the Ashes series against England after breaking down with another back injury.

Foreign fighters in Syria have moved to other places: India at UNSC

Foreign fighters in Syria have moved to other places: India at UNSC

Rediff.com21 Jan 2021

India has expressed concern that foreign fighters involved in the conflict in Syria have moved to other places as mercenaries, as New Delhi underlined that it is ready to play a constructive role in the Security Council to help realise the objective of the West Asian country reclaiming its place in the comity of nations.

Post COVID travel: 10 things to know

Post COVID travel: 10 things to know

Rediff.com21 Jul 2020

Gloves, masks, vitamin C, wet wipes and sanitisers are the new essentials you have to move around with.

Omicron: 200 Million Indians Yet To Be Vaccinated

Omicron: 200 Million Indians Yet To Be Vaccinated

Rediff.com24 Dec 2021

We need to give a booster shot to all our frontline workers first as if they fall victim to Omicron, the health system will collapse, points out Ramesh Menon.

Top US doctor cautiously optimistic over COVID vaccine

Top US doctor cautiously optimistic over COVID vaccine

Rediff.com9 Jul 2020

There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.

Cong leaders raise concern over emergency vaccine nod

Cong leaders raise concern over emergency vaccine nod

Rediff.com4 Jan 2021

Senior Congress leader Anand Sharma on Sunday raised concerns over India's drugs regulator granting permission for restricted use of Bharat Biotech's COVID-19 vaccine and asked the government to explain why mandatory protocols and verification of data has been dispensed with.

Kang claims AFI told him to drop out of World C'ships

Kang claims AFI told him to drop out of World C'ships

Rediff.com16 Aug 2017

He was not handed a provisional suspension as it was not mandatory under WADA rules.

Domestic firms to supply AIDS drug

Domestic firms to supply AIDS drug

Rediff.com5 May 2008

Domestic drug makers Cipla, Aurobindo and Matrix Laboratories have emerged as the second-line and paediatric AIDS medicine supply partners to international drug purchase facility UNITAID and Clinton Foundation HIV / AIDS Initiative in 2008. UNITAID and CHAI support HIV / AIDS treatment programmes in over 100 countries worldwide.

'Modi must resist US pressure on drug patents'

'Modi must resist US pressure on drug patents'

Rediff.com30 Sep 2014

Western drugmakers, including Pfizer Inc, Novartis AG, Roche Holding AG and Sanofi SA, covet a bigger share of the fast-growing Indian drugs market.

'The faster one vaccinates, the lower the infections'

'The faster one vaccinates, the lower the infections'

Rediff.com1 Mar 2021

'We are not yet out of the woods.' 'If India sees the South African or Brazilian type of mutations, our numbers will rapidly rise.'

'Modi govt failed to understand or to tackle COVID'

'Modi govt failed to understand or to tackle COVID'

Rediff.com1 May 2021

As India logged a world record of over four lakh coronavirus infections on Saturday, Congress leader Rahul Gandhi said the entire world is shaken by what is happening here and accused Prime Minister Narendra Modi of "dropping the ball and throwing it to states" after prematurely taking credit for having "won against COVID-19" when the second wave was already underway. "Rely on yourself is the motto. No one will come to help you. Definitely, not the prime minister," Gandhi said, while alleging that the COVID-19 situation has gone completely out of control for the Modi government, and wondered whether it was their way of making the states and the citizens truly 'Aatmanirbhar'.

PM urged to reject US pressure tactics on trade, biz policies

PM urged to reject US pressure tactics on trade, biz policies

Rediff.com28 Mar 2014

The unilateral pressure by US administration on India, at the behest of US Business Associations lobby through US International Trade Commission investigations and request to USTR to enlist India under Priority Foreign Country under Special 301 review, lacks legitimacy under WTO framework, the signatories to the letter said.

'Law not equipped to handle pharma monopoly'

'Law not equipped to handle pharma monopoly'

Rediff.com28 Jan 2008

With anti-competitive practices of global pharma companies increasingly coming under regulatory scrutiny internationally, Indian public interest groups and the domestic medicine makers complain that India's competitive laws are not equipped to face a similar situation of monopoly in the sales of patent protected medicines in the country.

Why price control for drugs is wrong

Why price control for drugs is wrong

Rediff.com19 Jun 2013

For the poorest 20 per cent of Indians, the expenditure on medicines alone is 85 per cent of what they spend on their health, according to the National Sample Survey.

What is the cost of education in Singapore?

What is the cost of education in Singapore?

Rediff.com9 Jan 2020

Undergraduate courses indicatively cost S$23,000 to S$38,000, while postgraduate courses approximately cost S$15,000 to S$40,000.

Drug regulator lets pharma firms fix own penalty

Drug regulator lets pharma firms fix own penalty

Rediff.com20 Jan 2014

Even as the Supreme Court had recently dismissed the industry's plea against prices fixed by the regulator and its timely implementation, the National Pharmaceutical Pricing Authority has asked companies to pay the overcharged dues with 15 per cent interest.